Palladium-mediated synthesis of poly-fused heterocycles from Baylis-Hillman adducts

Tetrahedron

Volumn 64, Issue 30-31, 2008, Pages 7183-7190

  Lee, Hyun Seung ^a   Kim, Sung Hwan ^a   Gowrisankar, Saravanan ^a   Kim, Jae Nyoung ^a  

^a Chonnam National University   (South Korea)

Author keywords

Baylis Hillman adducts; Benzimidazole; Heck reaction; Imidazole; Indole; Isatin; Palladium

Indexed keywords

BENZIMIDAZOLE; HETEROCYCLIC COMPOUND; IMIDAZOLE; INDOLE; ISATIN; PALLADIUM;

ARTICLE; BAYLIS HILLMAN REACTION; CHEMICAL MODIFICATION; HECK REACTION; PRIORITY JOURNAL; SYNTHESIS;

EID: 45449088876     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.05.087     Document Type: Article

References (86)

1. For the synthesis of medium-sized ring by Heck type cyclization, see:
2. Arnold L.A., Luo W., and Guy R.K. Org. Lett. 6 (2004) 3005-3007
3. Gibson S.E., Guillo N., and Tozer M.J. Chem. Commun. (1997) 637-638
4. Avila-Zarraga J.G., Lujan-Montelongo A., Covarrubias-Zuniga A., and Romero-Ortega M. Tetrahedron Lett. 47 (2006) 7987-7989
5. Soderberg B.C.G., Hubbard J.W., Rector S.R., and O'Neil S.N. Tetrahedron 61 (2005) 3637-3649
6. Donets P.A., and Van der Eycken E.V. Org. Lett. 9 (2007) 3017-3020
7. Rigby J.H., Hughes R.C., and Heeg M.J. J. Am. Chem. Soc. 117 (1995) 7834-7835
8. Joucla L., Popowycz F., Lozach O., Meijer L., and Joseph B. Helv. Chim. Acta 90 (2007) 753-763
9. For the examples of palladium-mediated inter- and intramolecular aryl-aryl couplings, see:
10. Alberico D., Scott M.E., and Lautens M. Chem. Rev. 107 (2007) 174-238 and further references cited therein
11. Lane B.S., and Sames D. Org. Lett. 6 (2004) 2897-2900
12. Campeau L.-C., Parisien M., Jean A., and Fagnou K. J. Am. Chem. Soc. 128 (2006) 581-590
13. Campeau L.-C., Parisien M., Leblanc M., and Fagnou K. J. Am. Chem. Soc. 126 (2004) 9186-9187
14. Campeau L.-C., Thansandote P., and Fagnou K. Org. Lett. 7 (2005) 1857-1860
15. Parisien M., Valette D., and Fagnou K. J. Org. Chem. 70 (2005) 7578-7584
16. Gomez-Lor B., and Echavarren A.M. Org. Lett. 6 (2004) 2993-2996
17. Seregin I.V., and Gevorgyan V. Chem. Soc. Rev. 36 (2007) 1173-1193
18. For the Pd-mediated arylation and Heck type cyclization involving indole moiety, see:
19. Routier S., Merour J.-Y., Dias N., Lansiaux A., Bailly C., Lozach O., and Meijer L. J. Med. Chem. 49 (2006) 789-799
20. Putey A., Joucla L., Picot L., Besson T., and Joseph B. Tetrahedron 63 (2007) 867-879
21. Kozikowski A.P., and Ma D. Tetrahedron Lett. 32 (1991) 3317-3320
22. Grigg R., Sridharan V., Stevenson P., Sukirthalingam S., and Worakun T. Tetrahedron 46 (1990) 4003-4018
23. Lane B.S., Brown M.A., and Sames D. J. Am. Chem. Soc. 127 (2005) 8050-8057
24. Lebrasseur N., and Larrosa I. J. Am. Chem. Soc. 130 (2008) 2926-2927
25. Stuart D.R., Villemure E., and Fagnou K. J. Am. Chem. Soc. 129 (2007) 12072-12073
26. For the Pd-mediated arylation of imidazole, benzimidazole, purine, and related azole derivatives, see:
27. Bellina F., Calandri C., Cauteruccio S., and Rossi R. Tetrahedron 63 (2007) 1970-1980
28. Bellina F., Cauteruccio S., and Rossi R. Eur. J. Org. Chem. (2006) 1379-1382
29. Bellina F., Cauteruccio S., Mannina L., Rossi R., and Viel S. Eur. J. Org. Chem. (2006) 693-703
30. Bellina F., Cauteruccio S., Mannina L., Rossi R., and Viel S. J. Org. Chem. 70 (2005) 3997-4005
31. Cerna I., Pohl R., and Hocek M. Chem. Commun. (2007) 4729-4730
32. Cerna I., Pohl R., Klepetarova B., and Hocek M. Org. Lett. 8 (2006) 5389-5392
33. For the general review on Baylis-Hillman reaction, see:
34. Basavaiah D., Rao A.J., and Satyanarayana T. Chem. Rev. 103 (2003) 811-891
35. Ciganek E. In: Paquette L.A. (Ed). Organic Reactions Vol. 51 (1997), John Wiley & Sons, New York, NY 201-350
36. Basavaiah D., Rao P.D., and Hyma R.S. Tetrahedron 52 (1996) 8001-8062
37. Kim J.N., and Lee K.Y. Curr. Org. Chem. 6 (2002) 627-645
38. Lee K.Y., Gowrisankar S., and Kim J.N. Bull. Korean Chem. Soc. 26 (2005) 1481-1490
39. Singh V., and Batra S. Tetrahedron 64 (2008) 4511-4574 and further references cited therein
40. For the Pd-mediated reactions involving Baylis-Hillman adducts, see:
41. Vasudevan A., Tseng P.-S., and Djuric S.W. Tetrahedron Lett. 47 (2006) 8591-8593
42. Coelho F., Veronese D., Pavam C.H., de Paula V.I., and Buffon R. Tetrahedron 62 (2006) 4563-4572
43. Ribiere P., Declerck V., Nedellec Y., Yadav-Bhatnagar N., Martinez J., and Lamaty F. Tetrahedron 62 (2006) 10456-10466
44. Declerck V., Ribiere P., Nedellec Y., Allouchi H., Martinez J., and Lamaty F. Eur. J. Org. Chem. (2007) 201-208
45. For our recent papers on the Pd-mediated reactions using the Baylis-Hillman adducts, see:
46. Gowrisankar S., Lee H.S., Kim J.M., and Kim J.N. Tetrahedron Lett. 49 (2008) 1670-1673
47. Kim J.M., Kim K.H., Kim T.H., and Kim J.N. Tetrahedron Lett. 49 (2008) 3248-3251
48. Gowrisankar S., Lee H.S., Lee K.Y., Lee J.-E., and Kim J.N. Tetrahedron Lett. 48 (2007) 8619-8622 and further references cited therein on the synthesis and biological activities of benzoazepino[2,1-a]isoindole moiety-containing compounds
49. Lee H.S., Kim S.H., Kim T.H., and Kim J.N. Tetrahedron Lett. 49 (2008) 1773-1776
50. For the preparation of benzoazepino[1,2-a]indole derivatives as inhibitors of hepatitis C virus (HCV) replication, see:
51. Hudyma, T. W.; Zheng, X.; He, F.; Ding, M.; Bergstrom, C. P.; Hewawasam, P.; Martin, S. W.; Gentles, R. G. WO 2007092000, 2007;
52. Chem. Abstr. 147 (2007) 277782
53. Meanwell, N. A.; Gentles, R. G.; Ding, M.; Bender, J. A.; Kadow, J. F.; Hewawasam, P.; Hudyma, T. W.; Zheng, X. US 2007,184,024, 2007;
54. Chem. Abstr. 147 (2007) 257667
55. Bergstrom, C. P.; Bender, J. A.; Gentles, R. G.; Hewawasam, P.; Hudyma, T. W.; Kadow, J. F.; Martin, S. W.; Regueiro-Ren, A.; Yeung, K. -S.; Tu, Y.; Grant-Young, K. A.; Zheng, X. WO 2007033175, 2007;
56. Chem. Abstr. 146 (2007) 358820
57. Bergstrom, C. P.; Martin, S. W.; Hudyma, T. W. US 2007,185,083, 2007;
58. Chem. Abstr. 147 (2007) 235031
59. Gentles, R. G.; Ding, M.; Hewawasam, P. US 2007,275,930, 2007;
60. Chem. Abstr. 148 (2007) 11085
61. For the synthesis and biological importance of 1,7-annulated indole derivatives, see:
62. Al-awar R.S., Ray J.E., Hecker K.A., Huang J., Waid P.P., Shih C., Brooks H.B., Spencer C.D., Watkins S.A., Patel B.R., Stamm N.B., Ogg C.A., Schultz R.M., Considine E.L., Faul M.M., Sullivan K.A., Kolis S.P., Grutsch J.L., and Joseph S. Bioorg. Med. Chem. Lett. 14 (2004) 3217-3220
63. Zhu G., Conner S.E., Zhou X., Chan H.-K., Shih C., Engler T.A., Al-awar R.S., Brooks H.B., Watkins S.A., Spencer C.D., Schultz R.M., Dempsey J.A., Considine E.L., Patel B.R., Ogg C.A., Vasudevan V., and Lytle M.L. Bioorg. Med. Chem. Lett. 14 (2004) 3057-3061
64. Van Wijngaarden I., Hamminga D., van Hes R., Standaar P.J., Tipker J., Tulp M.Th., Mol F., Olivier B., and de Jonge A. J. Med. Chem. 36 (1993) 3693-3699
65. Toscano L., Grisanti G., Fioriello G., Seghetti E., Bianchetti A., Bossoni G., and Riva M. J. Med. Chem. 19 (1976) 208-213
66. For the synthesis and biological importance of tetracyclic indole derivatives, see:
67. Bressy C., Alberico D., and Lautens M. J. Am. Chem. Soc. 127 (2005) 13148-13149 and further references cited therein
68. Ikegashira K., Oka T., Hirashima S., Noji S., Yamanaka H., Hara Y., Adachi T., Tsuruha J.-I., Doi S., Hase Y., Noguchi T., Ando I., Ogura N., Ikeda S., and Hashimoto H. J. Med. Chem. 49 (2006) 6950-6953
69. Faust R., Garratt P.J., Jones R., Yeh L.-K., Tsotinis A., Panoussopoulou M., Calogeropoulou T., Teh M.-T., and Sugden D. J. Med. Chem. 43 (2000) 1050-1061
70. Rivara S., Mor M., Silva C., Zuliani V., Vacondio F., Spadoni G., Bedini A., Tarzia G., Lucini V., Pannacci M., Fraschini F., and Plazzi P.V. J. Med. Chem. 46 (2003) 1429-1439
71. Rigby J.H., and Mateo M.E. Tetrahedron 52 (1996) 10569-10582
72. Torres J.C., Pinto A.C., and Garden S.J. Tetrahedron 60 (2004) 9889-9900
73. Kunick C., Lauenroth K., Wieking K., Xie X., Schultz C., Gussio R., Zaharevitz D., Leost M., Meijer L., Weber A., Jorgensen F.S., and Lemcke T. J. Med. Chem. 47 (2004) 22-36
74. Leost M., Schultz C., Link A., Wu Y.-Z., Biernat J., Mandelkow E.-M., Bibb J.A., Snyder G.L., Greengard P., Zaharevitz D.W., Gussio R., Senderowicz A.M., Sausville E.A., Kunick C., and Meijer L. Eur. J. Biochem. 267 (2000) 5983-5994
75. Stukenbrock H., Mussmann R., Geese M., Ferandin Y., Lozach O., Lemcke T., Kegel S., Lomow A., Burk U., Dohrmann C., Meijer L., Austen M., and Kunick C. J. Med. Chem. 51 (2008) 2196-2207
76. For the synthesis of eight-membered cyclic compounds, see:
77. Appukkuttan P., Dehaen W., and der Eycken E.V. Org. Lett. 7 (2005) 2723-2726
78. Appukkuttan P., Dehaen W., and der Eycken E.V. Chem.-Eur. J. 13 (2007) 6452-6460
79. Trost B.M., and Ameriks M.K. Org. Lett. 6 (2004) 1745-1748
80. Voskressensky L.G., Listratova A.V., Borisova T.N., Alexandrov G.G., and Varlamov A.V. Eur. J. Org. Chem. (2007) 6106-6117
81. Ikemoto T., Ito T., Nishiguchi A., and Tomimatsu K. Tetrahedron Lett. 45 (2004) 9335-9339
82. Panayides J.-L., Pathak R., Panagiotopoulos H., Davids H., Fernandes M.A., de Koning C.B., and van Otterlo W.A.L. Tetrahedron 63 (2007) 4737-4747
83. Voskressensky L.G., Borisova T.N., Listratova A.V., Kulikova L.N., Titov A.A., and Varlamov A.V. Tetrahedron Lett. 47 (2006) 4585-4589
84. Basavaiah D., and Aravindu K. Org. Lett. 9 (2007) 2453-2456
85. Dieltiens N., Stevens C.V., Masschelein K., Hennebel G., and der Jeught S.V. Tetrahedron 64 (2008) 4295-4303
86. Seto M., Aikawa K., Miyamoto N., Aramaki Y., Kanzaki N., Takashima K., Kuze Y., Iizawa Y., Baba M., and Shiraishi M. J. Med. Chem. 49 (2006) 2037-2048